Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Electromed Inc (ELMD)

Electromed Inc (ELMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Electromed Inc 500 SIXTH AVENUE NW NEW PRAGUE MN 56071 USA

www.smartvest.com Employees: 180 P: 952-758-9299

Sector:

Medical

Description:

Electromed, Inc. manufactures, markets and sells products that provide airway clearance therapy to patients with compromised pulmonary function. The Company is the designer, manufacturer and worldwide provider of the SmartVest' Airway Clearance System and related products. The patented system uses High Frequency Chest Wall Oscillation (HFCWO), an alternative to Chest Physiotherapy (CPT), to deliver airway clearance treatment. The Company manufactures its products for use by chronically-ill patients who face health risks due to pneumonia and mucus accumulation in the lungs, particularly patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company's products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota.

Key Statistics

Overview:

Market Capitalization, $K 231,866
Enterprise Value, $K 216,576
Shares Outstanding, K 8,340
Annual Sales, $ 64,000 K
Annual Net Income, $ 7,540 K
Last Quarter Sales, $ 16,890 K
Last Quarter Net Income, $ 2,140 K
EBIT, $ 10,390 K
EBITDA, $ 11,770 K
60-Month Beta 0.26
% of Insider Shareholders 10.50%
% of Institutional Shareholders 40.82%
Float, K 7,465
% Float 89.50%
Short Volume Ratio 0.60

Growth:

1-Year Return -0.68%
3-Year Return 177.72%
5-Year Return 193.25%
5-Year Revenue Growth 97.11%
5-Year Earnings Growth 80.85%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.25 on 11/12/25
Next Earnings Date N/A
Earnings Per Share ttm 0.93
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 56.25%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ELMD Ratios

Ratio
Price/Earnings ttm 30.05
Price/Earnings forward 26.12
Price/Earnings to Growth N/A
Return-on-Equity % 18.59%
Return-on-Assets % 15.46%
Profit Margin % 11.78%
Debt/Equity 0.00
Price/Sales 3.64
Price/Cash Flow 26.27
Price/Book 5.23
Book Value/Share 5.34
Interest Coverage -1.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar